menu
    • menu

    Company profile for BeOne Medicines

    NEW Drugs in Dev: 65
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BeOne Medicines, based in Switzerland, is a global oncology company dedicated to discovering and developing innovative, affordable cancer treatments. Its portfolio covers both hematology and solid tumors, and it advances its diverse pipeline through strong in-house expertise and strategic collaborations. With over 11,000 employees across six continents, BeOne is driven by a mission to significantly expand access to life-changi...
    BeOne Medicines, based in Switzerland, is a global oncology company dedicated to discovering and developing innovative, affordable cancer treatments. Its portfolio covers both hematology and solid tumors, and it advances its diverse pipeline through strong in-house expertise and strategic collaborations. With over 11,000 employees across six continents, BeOne is driven by a mission to significantly expand access to life-changing medicines for cancer patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BeOne MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://beonemedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/beonemedicines/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Beonemedicines

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BeOne Medicine Licenses Trispecific PD-1/CTLA-4/VEGF Antibody
    BeOne Medicine Licenses Trispecific PD-1/CTLA-4/VEGF Antibody

    28 Apr 2026

    // ENDPOINTS

    https://endpoints.news/beone-medicines-licenses-trispecific-antibody-targeting-pd-1-ctla-4-and-vegf/

    ENDPOINTS
    28 Apr 2026
    Share Share
    China Signs Off On Amgen's Imdelltra
    China Signs Off On Amgen's Imdelltra

    10 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026

    FIERCE PHARMA
    10 Apr 2026
    Share Share
    BeOne Launches Tislelizumab For Advanced Oesophageal Cancer
    BeOne Launches Tislelizumab For Advanced Oesophageal Cancer

    10 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-10/beone-s-tislelizumab-now-available-in-ireland-offering-a-new-first-line-immunotherapy-option-for-advanced-oesophageal-cancer

    PHARMIWEB
    10 Mar 2026
    Share Share
    Beone Medicines To Present At Upcoming Investor Conferences
    Beone Medicines To Present At Upcoming Investor Conferences

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217750246/en/BeOne-Medicines-to-Present-at-Upcoming-Investor-Conferences

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    BeOne Medicines To Release 2025 Q4 And Full-Year Financials
    BeOne Medicines To Release 2025 Q4 And Full-Year Financials

    11 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260211141441/en/BeOne-Medicines-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-26

    BUSINESSWIRE
    11 Feb 2026
    Share Share
    InSysBio to Announce a Collaborative Project with BeOne Medicines
    InSysBio to Announce a Collaborative Project with BeOne Medicines

    28 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/insysbio-to-announce-a-new-collaborative-project-with-beone-medicines-302669033.html

    PR NEWSWIRE
    28 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search